Meeting
2020 Genitourinary Cancers Symposium
A phase I clinical trial of PSMA-directed/TGFβ-insensitive CAR-T cells in metastatic castration-resistant prostate cancer.
Authors
Vivek Narayan
University of Pennsylvania, Philadelphia, PA
Vivek Narayan , Whitney Gladney , Gabriela Plesa , Neha Vapiwala , Erica L. Carpenter , Shannon L. Maude , Priti Lal , Simon F. Lacey , Jan J. Melenhorst , Joseph Fraietta , Ronnie Sebro , Michael Farwell , Michael Moniak , Joan Gilmore , Lester Lledo , Karen Dengel , Amy Marshall , Christina Marie Coughlin , Carl H. June , Naomi B. Haas
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT03089203
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr TPS269)
Abstract #
TPS269
Poster Bd #
P13
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
A phase I clinical trial of PSMA-directed/TGFβ-insensitive CAR-T cells in metastatic castration-resistant prostate cancer.
First Author: Vivek Narayan
Poster
2021 Genitourinary Cancers Symposium
A phase I clinical trial of PSMA-directed/TGFβ-insensitive CAR-T cells in metastatic castration-resistant prostate cancer.
First Author: Vivek Narayan
Poster
2022 ASCO Genitourinary Cancers Symposium
Phase 1 study of P-PSMA-101 CAR-T cells in patients with metastatic castration-resistant prostate cancer (mCRPC).
First Author: Susan F. Slovin
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A phase I study of GPC3 targeted CAR-T cell therapy in advanced GPC3-expressing hepatocellular carcinoma (HCC).
First Author: Changqing Xie